| Literature DB >> 36226056 |
Fangyuan Gong1, Lei Jin1, Qiuwei Song2, Zhong Yang3, Hong Chen4, Jinsong Wu1.
Abstract
Objective: Cingulate cortex and cingulum both play crucial roles in limbic system. The aim of study is to observe and analyze surgical outcomes of cingulate gyrus glioma through extents of resection (EORs), overall survival (OS), and postsurgical neurological outcome. Method: The authors retrospectively studied 95 consecutive adult cases of primary cingulate gliomas that all underwent craniotomies and tumor resection. The patients were classified into unitary sub-region based on the four-division model. The information of clinical symptoms, pathology, EOR, postoperative neurological outcome and survival were analyzed through group comparison. Result: Low-grade gliomas (LGGs) were more prevalent (69.47%) for cingulate gyrus. Diffuse astrocytoma (40.00%) was most common histopathological diagnosis in total. Regarding sub-regions tumor involved in, midcingulate cortex (MCC) glioma was most prevalent (54.74%) followed by anterior cingulate cortex (ACC) glioma. Among all patients, 83 patients (87.37%) received EOR ≥ 90%. In LGG group, 58 patients (87.88%) received EOR ≥ 90%. The achievement of EOR significantly correlated with survival (P = 0.006). MCC cases were significantly associated with short-term morbidity in either language or motor function (P = 0.02). Majority of ACC cases (80.65%) escaped from any short-term deficits and nearly 90% free for permanent morbidity. Tumors in the dominant hemisphere were significantly associated with language dysfunction or cognition dysfunction, either short-term (P=0.0006) or long-term morbidity (P=0.0111). Age was the only postoperative susceptible predictor for all types of transient (P=0.021) and permanent (P=0.02) neurological deficit.Entities:
Keywords: cingulate; glioma; oncology; prognosis; subregion; surgery
Year: 2022 PMID: 36226056 PMCID: PMC9549335 DOI: 10.3389/fonc.2022.986387
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 5.738
Figure 1The illustration of four cingulate subregions and nearby motor related areas. AC, Anterior Commissure; PC, Posterior Commissure; VCA, Vertical Plane at the AC; VCP, VCA: Vertical Plane at the PC.
Summary of Clinical characteristics in 95 patients.
| Parameter | Result (Total N=95) | ||
|---|---|---|---|
| Age at diagnosis (years) | |||
| Median | 40 | ||
| Range | 19-70 | ||
| Gender (cases) | |||
| Male | 52 | ||
| Female | 43 | ||
| Cingulate gyrus glioma type (cases) | |||
| Pure CG glioma (tumor restraining within cingulate gyrus) | 65 | ||
| Diffuse CG glioma (tumor extending to non-cingulate gyrus) | 30 | ||
| Side of tumor (cases) | |||
| Left | 54 | ||
| Right | 41 | ||
| Main clinical symptoms (cases) | |||
| Epilepsy | 54 | ||
| Motor weakness | 20 | ||
| Headache with nausea | 32 | ||
| Disorder in memory | 14 | ||
| WHO Grade (cases) | |||
| 2 | 66 | ||
| 3 | 18 | ||
| 4 | 11 | ||
| Pathology (cases) | |||
| Astrocytoma, IDH-mutation, Grade 2 | 31 | ||
| Astrocytoma,IDH-mutation, Grade 3 | 6 | ||
| Oligodendroglioma,1p/19q Co-deletion, IDH-mutation, Grade 2 | 23 | ||
| Glioblastoma, IDH-wildtype, Grade 4 | 9 | ||
| Astrocytoma, IDH-wildtype, NEC, Grade 2 | 11 | ||
| Astrocytoma, IDH-wildtype, NEC, Grade 3 | 6 | ||
| Oligodendroglioma, 1p/19q Co-deletion, IDH-mutation, Grade 3 | 6 | ||
| Astrocytoma, IDH-mutation, Grade 4 | 2 | ||
| Pleomorphic xanthoastrocytoma | 1 | ||
Figure 2The distribution of cingulate gyrus glioma classified by sub-region.
Summary of tumor volume and EOR (extent of resection) in 95 patients.
| Index | All patients | Group | LGG | HGG | |||||
|---|---|---|---|---|---|---|---|---|---|
| ACC* | MCC* | PCC* | Pure CG | Diffuse CG | |||||
| Median tumor volume (cm3) | 40.26 | 53.29 | 49.75 | 37.71 | 37.19 | 87.06 | 41.10 | 38.73 | |
| ≥90% (Cases) | 83 | 45 | 45 | 17 | 57 | 26 | 58 | 14 (=100%) | |
| <90% (Cases) | 12 | 4 | 7 | 12 | 8 | 4 | 8 | 15 (<100%) | |
|
| Mean (%) | 96.06 | 97.38 | 94.77 | 94.32 | 96.04 | 96.13 | 95.62 | 95.73 |
| Median (%) | 100.00 | 100.00 | 94.71 | 93.42 | 100.00 | 100.00 | 100 | 99.76 | |
| Range (%) | 83.96-100.00 | 83.96-100.00 | 84.01-100.00 | 85.40-100.00 | 83.96-100.00 | 84.01-100.00 | 81.27-100.00 | 82.65-100.00 | |
*Subregion in table included all patients where tumor involved in (either alone or in combination with other zones).
All patients, n = 95; Tumor involved in ACC, n = 49; Tumor involved in MCC, n = 52; Tumor involved in PCC, n = 29.
Summary of function deficits and clinical symptoms in classified groups.
| Distribution | No. of patients | Postoperative short-term (within one month) morbidity cases | ||||
|---|---|---|---|---|---|---|
| Language | Motor | Language with motor | Cognition | Seizure | ||
| ACC | 31 | 4 | 3 | 2 | 2 | 1 |
| MCC | 26 | 15 | 10 | 9 | 4 | 3 |
| PCC | 12 | 3 | 4 | 1 | 3 | 0 |
| ACC+MCC | 17 | 5 | 5 | 1 | 1 | 3 |
| MCC+PCC | 8 | 3 | 2 | 2 | 3 | 0 |
| ACC+MCC+PCC | 1 | 0 | 0 | 0 | 0 | 0 |
|
| ||||||
| ACC | 31 | 3 | 1 | 0 | 0 | 0 |
| MCC | 26 | 2 | 3 | 1 | 1 | 0 |
| PCC | 12 | 2 | 2 | 0 | 0 | 0 |
| ACC+MCC | 17 | 0 | 2 | 0 | 1 | 2 |
| MCC+PCC | 8 | 2 | 1 | 0 | 1 | 0 |
| ACC+MCC+PCC | 1 | 0 | 0 | 0 | 0 | 0 |
Summary of relationship between function deficits and distribution of sub-region.
| Parameter (Subregion involved) | Postoperative short-term (within one month) morbidity | |||||
|---|---|---|---|---|---|---|
| Language | Motor | Language with motor | Cognition | Seizure | ||
| Pure CG glioma | ||||||
| ACC* n=25 | 5 | 4 | 2 | 2 | 3 | |
| MCC* n=39 | 17 | 13 | 10 | 7 | 4 | |
| PCC* n=19 | 5 | 5 | 3 | 4 | 0 | |
| All CG glioma | ||||||
| ACC* n=49 | 9 | 8 | 2 | 3 | 4 | |
| MCC* n=52 | 23 | 17 | 12 | 8 | 6 | |
| PCC* n=29 | 6 | 6 | 3 | 6 | 0 | |
|
|
| |||||
|
|
|
|
|
| ||
| Pure CG glioma | ||||||
| ACC* n=25 | 2 | 2 | 0 | 1 | 2 | |
| MCC* n=39 | 4 | 6 | 1 | 3 | 2 | |
| PCC* n=19 | 3 | 2 | 0 | 2 | 0 | |
| All CG glioma | ||||||
| ACC* n=49 | 3 | 3 | 0 | 1 | 2 | |
| MCC* n=52 | 4 | 6 | 1 | 3 | 2 | |
| PCC* n=29 | 4 | 3 | 0 | 2 | 0 | |
Subregion* in table included all patients whose tumor involved the area (either alone or in combination with other areas).
Summary of relationship between function deficits and dominant hemisphere.
| Parameter (Tumor side) | Postoperative short-term (within one month) morbidity | |||||||
|---|---|---|---|---|---|---|---|---|
| Language | Motor | Language with motor | Cognition | Seizure | ||||
| Pure CG glioma | ||||||||
| Dominant hemisphere | 20 | 13 | 11 | 9 | 2 | |||
| Non-dominant hemisphere | 2 | 4 | 1 | 0 | 3 | |||
| All CG glioma | ||||||||
| Dominant hemisphere n=58 | 26 | 18 | 13 | 13 | 4 | |||
| Non-dominant hemisphere n=37 | 4 | 6 | 1 | 0 | 3 | |||
|
|
| |||||||
|
|
|
|
|
| ||||
| Pure CG glioma | ||||||||
| Dominant hemisphere | 7 | 4 | 1 | 3 | 1 | |||
| Non-dominant hemisphere | 0 | 3 | 0 | 0 | 1 | |||
| All CG glioma | ||||||||
| Dominant hemisphere n=58 | 9 | 5 | 1 | 3 | 1 | |||
| Non-dominant hemisphere n=37 | 0 | 4 | 0 | 0 | 1 | |||
|
|
|
|
| |||||
| Short-term (Dominant hemisphere) | 6.703 | 2.21-19.1 | 0.0006 | |||||
| Long-term (Dominant hemisphere) | 6.353 | 1.77-99.9 | 0.0111 | |||||
Analysis of multivariate logistic regression for postsurgical deficit.
| Factors | Short-term | Long-term | ||||
|---|---|---|---|---|---|---|
| OR | 95%CI | P value | OR | 95%CI | P value | |
| Tumor growing type (Diffuse tumor) | 1.745 | 0.641-4.746 | 0.276 | 0.698 | 0.17-2.867 | 0.618 |
| Sub-region (MCC) | 3.014 | 1.274-7.129 | 0.020 | 1.454 | 0.423-4.994 | 0.552 |
| Dominant hemisphere | 3.442 | 1.274-9.296 | 0.015 | 2.433 | 0.704-8.406 | 0.16 |
| Grade (LGG) | 0.872 | 0.312-2.437 | 0.794 | 0.527 | 0.423-4.994 | 0.374 |
| Age | 1.046 | 1.007-1.087 | 0.021 | 1.062 | 1.010-1.116 | 0.02 |
| Extent of Resection | 0.004 | 0.000-41.613 | 0.242 | 2.887 | 0.706-11.802 | 0.14 |
Multivariate analyses of overall survival outcome in CG patients.
| Multivariate analysis | P Value | HR | 95%CI | |
|---|---|---|---|---|
| Lower | Upper | |||
| Age | 0.180 | 0.975 | 0.939 | 1.012 |
| Tumor growing type (Diffuse type) | 0.037 | 3.911 | 1.089 | 14.038 |
| Sub-region (Non-MCC) | 0.244 | 0.498 | 0.154 | 1.608 |
| WHO Grade (LGG) | 0.004 | 0.146 | 0.04 | 0.541 |
| IDH (Mutant) | <0.0001 | 0.031 | 0.005 | 0.185 |
| Tumor volume | 0.944 | 0.999 | 0.978 | 1.021 |
| Extent of resection | 0.006 | 0.212 | 0.066 | 0.678 |
Recommendable regimen of surgical approach and techniques for pure CG glioma in different sub-region.
| ACC | ACC and MCC boundary | MCC | PCC | |
|---|---|---|---|---|
| Common chief complaint | Seizure attack | Seizure attack | Motor weakness | Motor weakness |
|
| ||||
|
| Supine position with head flexed | Supine position with head flexed | Supine position with upper body raised | Prone position with neck flexed |
|
| Coronal incision | Horseshoe shaped incision | Horseshoe shaped incision | U-shaped incision or paramedian straight incision |
|
| Trans-longitudinal fissure approach | Trans-longitudinal fissure approach | Trans medial frontal cortical approach | Trans precuneus cortical approach |
|
| ||||
|
| Necessary | Necessary | Necessary | Necessary |
|
| Depend on evaluation | Necessary (Motor) | Necessary (Language + Motor) | Necessary (Motor) |
|
| Depend on evaluation | Necessary (Motor) | Necessary (Language + Motor) | Necessary (Motor) |
|
| ||||
|
| Intravenous anesthesia | Intravenous anesthesia | Awake anesthesia | Intravenous anesthesia or Awake anesthesia |
|
| Not applicable | Necessary (MEP monitoring) | Necessary (Transcortical MEP +SSEP) | Necessary (MEP monitoring + SSEP, or transcortical MEP + SSEP for awake anesthesia |
|
| Not applicable | Not applicable | Ojemann stimulator (5 mm-interval bipolar electrodes, current-constant bipolar square wave, 1-ms wave width, 60 Hz frequency) | |
|
| Not applicable | Transcortical MEP monitoring, strip electrode being put on the posterior side of surgical field | Stimulate the paracentral lobule until reliable motor responses were induced. Language mapping current was set to the same intensity | Stimulate the paracentral lobule until reliable motor/sensory responses were induced |
|
| ACA, Orbital-frontal A., | Pericallosal A., | Pericallosal A., | Pericallosal A., PCA |
MEP, motor evoked potential; SSEP, Somatosensory evoked potential; ACA, anterior cerebral artery; PCA, posterior cerebral artery.